All data are based on the daily closing price as of May 12, 2026
c
Center Laboratories
4123.TWO
1.22 USD
0.00
0.00%
Overview
Last close
1.22 usd
Market cap
922.11M usd
52 week high
1.57 usd
52 week low
0.93 usd
Target price
N/A usd
Valuation
P/E
3.3523
Forward P/E
2500
Price/Sales
19.1777
Price/Book Value
1.0863
Enterprise Value
1.03B usd
EV/Revenue
21.4378
EV/EBITDA
2.7208
Key financials
Revenue TTM
48.09M usd
Gross Profit TTM
19.70M usd
EBITDA TTM
-6.37M usd
Earnings per Share
0.36 usd
Dividend
N/A usd
Total assets
1.10B usd
Net debt
142.03M usd
About
Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.